Tifacogin, recombinant tissue factor pathway inhibitor.
Matyal
Robina
R
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Mahmood
Feroze
F
Park
Kyung W
KW
D000818:Animals; D003324:Coronary Artery Disease / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008074:Lipoproteins / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use; D011506:Proteins / Q000494:pharmacology* / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D008074:Lipoproteins; D011506:Proteins; C051928:lipoprotein-associated coagulation inhibitor; C400709:Tifacogin